MedCap AB (publ) (FRA:61MA)

MedCap AB Statistics

Total Valuation

MedCap AB has a market cap or net worth of EUR 679.35 million. The enterprise value is 690.53 million.

Market Cap	679.35M
Enterprise Value	690.53M

Important Dates

The last earnings date was Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	15.02M
Shares Outstanding	n/a
Shares Change (YoY)	+1.20%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	11.87M

Valuation Ratios

The trailing PE ratio is 33.45.

PE Ratio	33.45
Forward PE	n/a
PS Ratio	3.49
PB Ratio	5.04
P/TBV Ratio	32.95
P/FCF Ratio	23.19
P/OCF Ratio	21.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.95, with an EV/FCF ratio of 23.57.

EV / Earnings	34.00
EV / Sales	3.50
EV / EBITDA	16.95
EV / EBIT	26.18
EV / FCF	23.57

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.33.

Current Ratio	2.01
Quick Ratio	1.46
Debt / Equity	0.33
Debt / EBITDA	1.11
Debt / FCF	1.52
Interest Coverage	11.36

Financial Efficiency

Return on equity (ROE) is 16.07% and return on invested capital (ROIC) is 13.77%.

Return on Equity (ROE)	16.07%
Return on Assets (ROA)	7.66%
Return on Invested Capital (ROIC)	13.77%
Return on Capital Employed (ROCE)	13.34%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	329,029
Profits Per Employee	34,308
Employee Count	592
Asset Turnover	0.92
Inventory Turnover	3.23

Taxes

In the past 12 months, MedCap AB has paid 6.31 million in taxes.

Income Tax	6.31M
Effective Tax Rate	23.63%

Stock Price Statistics

The stock price has increased by +21.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.48%
50-Day Moving Average	48.07
200-Day Moving Average	48.95
Relative Strength Index (RSI)	40.08
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedCap AB had revenue of EUR 194.79 million and earned 20.31 million in profits. Earnings per share was 1.36.

Revenue	194.79M
Gross Profit	114.22M
Operating Income	26.03M
Pretax Income	26.70M
Net Income	20.31M
EBITDA	40.20M
EBIT	26.03M
Earnings Per Share (EPS)	1.36

Balance Sheet

The company has 34.23 million in cash and 44.62 million in debt, with a net cash position of -10.40 million.

Cash & Cash Equivalents	34.23M
Total Debt	44.62M
Net Cash	-10.40M
Net Cash Per Share	n/a
Equity (Book Value)	134.81M
Book Value Per Share	8.93
Working Capital	45.93M

Cash Flow

In the last 12 months, operating cash flow was 31.67 million and capital expenditures -2.37 million, giving a free cash flow of 29.29 million.

Operating Cash Flow	31.67M
Capital Expenditures	-2.37M
Free Cash Flow	29.29M
FCF Per Share	n/a

Margins

Gross margin is 58.64%, with operating and profit margins of 13.36% and 10.43%.

Gross Margin	58.64%
Operating Margin	13.36%
Pretax Margin	13.71%
Profit Margin	10.43%
EBITDA Margin	20.64%
EBIT Margin	13.36%
FCF Margin	15.04%

Dividends & Yields

MedCap AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.20%
Shareholder Yield	-1.20%
Earnings Yield	2.99%
FCF Yield	4.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5